Published “Efficacy and safety of first-line rituximab in severe, acquired thrombotic thrombocytopenic purpura with a suboptimal response to plasma exchange. Experience of the French Thrombotic Microangiopathies Reference Center” in Critical Care Medicine — cited 247 times.
- #crossref
- #research
- #work